BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9593128)

  • 1. Drug evaluation of concurrent Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium complex infections in a rat model.
    Brun-Pascaud M; Rajagopalan-Levasseur P; Chau F; Bertrand G; Garry L; Derouin F; Girard PM
    Antimicrob Agents Chemother; 1998 May; 42(5):1068-72. PubMed ID: 9593128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental evaluation of roxithromycin combined with dapsone or sulphamethoxazole on Pneumocystis carinii and Toxoplasma gondii dual infections in a rat model.
    Brun-Pascaud M; Chau F; Derouin F; Girard PM
    J Antimicrob Chemother; 1998 Mar; 41 Suppl B():57-62. PubMed ID: 9579714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of PS-15, epiroprim, or pyrimethamine with dapsone in prophylaxis of Toxoplasma gondii and Pneumocystis carinii dual infection in a rat model.
    Brun-Pascaud M; Chau F; Garry L; Jacobus D; Derouin F; Girard PM
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2067-70. PubMed ID: 8878582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental evaluation of combined prophylaxis against murine pneumocystosis and toxoplasmosis.
    Brun-Pascaud M; Chau F; Simonpoli AM; Girard PM; Derouin F; Pocidalo JJ
    J Infect Dis; 1994 Sep; 170(3):653-8. PubMed ID: 8077724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study on the efficacy of epiroprim against developmental stages of Toxoplasma gondii and Pneumocystis carinii in animal models.
    Mehlhorn H; Dankert W; Hartman PG; Then RL
    Parasitol Res; 1995; 81(4):296-301. PubMed ID: 7624286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered trimethoprim-sulfamethoxazole ratios for prophylaxis and treatment of Toxoplasma gondii and Pneumocystis carinii dual infections in rat model.
    Brun-Pascaud M; Chau F; Garry L; Farinotti R; Derouin F; Girard PM
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Nov; 13(3):201-7. PubMed ID: 8898664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the activities of rifabutin combined with atovaquone or low-dose of cotrimoxazole for prevention of pneumocystosis and toxoplasmosis in a dual infection rat model.
    Brun-Pascaud M; Chau F; Rajagopalan-Levasseur P; Derouin F; Girard PM
    J Eukaryot Microbiol; 1996; 43(5):14S-15S. PubMed ID: 8822822
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of Pneumocystis carinii pneumonia and of cerebral toxoplasmosis by roxithromycin in HIV-infected patients.
    Durant J; Hazime F; Carles M; Pechere JC; Dellamonica P
    Infection; 1995; 23 Suppl 1():S33-8. PubMed ID: 7782114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipophilic antifolates as agents against opportunistic infections. 1. Agents superior to trimetrexate and piritrexim against Toxoplasma gondii and Pneumocystis carinii in in vitro evaluations.
    Piper JR; Johnson CA; Krauth CA; Carter RL; Hosmer CA; Queener SF; Borotz SE; Pfefferkorn ER
    J Med Chem; 1996 Mar; 39(6):1271-80. PubMed ID: 8632434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinically used antimicrobial drugs against experimental pneumocystosis, singly and in combination: analysis of drug interactions and efficacies.
    Walzer PD; Runck J; Orr S; Foy J; Steele P; White M
    Antimicrob Agents Chemother; 1997 Feb; 41(2):242-50. PubMed ID: 9021174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumocystis carinii and Mycobacterium avium-intracellulare infection of the choroid.
    Whitcup SM; Fenton RM; Pluda JM; De Smet MD; Nussenblatt RB; Chan CC
    Retina; 1992; 12(4):331-5. PubMed ID: 1485017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and antifolate activity of new analogues of piritrexim and other diaminopyrimidine dihydrofolate reductase inhibitors with omega-carboxyalkoxy or omega-carboxy-1-alkynyl substitution in the side chain.
    Chan DC; Fu H; Forsch RA; Queener SF; Rosowsky A
    J Med Chem; 2005 Jun; 48(13):4420-31. PubMed ID: 15974594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.
    Bucher HC; Griffith L; Guyatt GH; Opravil M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jun; 15(2):104-14. PubMed ID: 9241108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium dihydrofolate reductases by 2,4-diamino-5-[2-methoxy-5-(omega-carboxyalkyloxy)benzyl]pyrimidines: marked improvement in potency relative to trimethoprim and species selectivity relative to piritrexim.
    Rosowsky A; Forsch RA; Queener SF
    J Med Chem; 2002 Jan; 45(1):233-41. PubMed ID: 11754594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antiparasitic and antitumor activity of 2, 4-diamino-6-(arylmethyl)-5,6,7,8-tetrahydroquinazoline analogues of piritrexim.
    Rosowsky A; Papoulis AT; Forsch RA; Queener SF
    J Med Chem; 1999 Mar; 42(6):1007-17. PubMed ID: 10090784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of de novo folate synthesis in Pneumocystis carinii and Toxoplasma gondii: potential for screening therapeutic agents.
    Kovacs JA; Allegra CJ; Beaver J; Boarman D; Lewis M; Parrillo JE; Chabner B; Masur H
    J Infect Dis; 1989 Aug; 160(2):312-20. PubMed ID: 2527275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of experimental Toxoplasma gondii infection by clarithromycin-based combination therapy with minocycline or pyrimethamine.
    Alder J; Hutch T; Meulbroek JA; Clement JC
    J Acquir Immune Defic Syndr (1988); 1994 Nov; 7(11):1141-8. PubMed ID: 7932081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a class of sulfonamides highly active against dihydropteroate synthase form Toxoplasma gondii, Pneumocystis carinii, and Mycobacterium avium.
    Chio LC; Bolyard LA; Nasr M; Queener SF
    Antimicrob Agents Chemother; 1996 Mar; 40(3):727-33. PubMed ID: 8851601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV: opportunistic infections.
    Ioannidis J; Wilkinson D
    Clin Evid; 2003 Jun; (9):795-816. PubMed ID: 15366175
    [No Abstract]   [Full Text] [Related]  

  • 20. AIDS related opportunistic infections, going but not gone.
    Samuel R; Bettiker RL; Suh B
    Arch Pharm Res; 2002 Jun; 25(3):215-28. PubMed ID: 12135090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.